Preliminary toxicity and prostate-specific antigen response of a Phase I/II trial of neoadjuvant hormonal therapy, 103Pd brachytherapy, and three-dimensional conformal external beam irradiation in the treatment of locally advanced prostate cancer•
1999 ◽
Vol 45
(3)
◽
pp. 258-259
◽
1994 ◽
Vol 28
(1)
◽
pp. 67-75
◽
2006 ◽
Vol 80
(1)
◽
pp. 62-68
◽
2008 ◽
Vol 7
(3)
◽
pp. 117
◽
2012 ◽
Vol 84
(3)
◽
pp. S92